ArticleThe Journal of biological chemistry2019

Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.

Bruce J MacLachlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.